安申布纳奥糖对阿尔茨海默病老鼠模型认知功能障碍的神经保护作用
Yuanfang Sun1, Qi Xia2, Lijing Du1
1School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China; The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
概括
安申白糖通过改善认知功能和减少神经元损伤,显示出治疗阿尔茨海默病 (AD) 的潜力. 这种传统中医药可能为阿尔茨海默病的预防和治疗提供新的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 传统中国医药 传统中国医药
背景情况:
- 阿尔茨海默病 (AD) 是一种流行的神经退行性疾病,没有治疗方法,需要开发有效的治疗方法.
- 传统中国医学 (TCM),如安申布纳糖,具有神经保护性质,需要对阿尔茨海默病治疗进行调查.
- 在阿尔茨海默病中,安申布纳奥糖治疗作用的确切机制在很大程度上仍未被探索.
研究的目的:
- 为了研究Anshen Bunao Syrup在斯科波胺诱导的阿尔茨海默病 (AD) 鼠标模型中的治疗潜力.
- 阐明安布纳奥糖的神经保护机制,重点关注其对认知功能,神经元损伤和关键病理标志物的影响.
- 在AD的背景下,探索安申布纳奥糖治疗所影响的代谢途径.
主要方法:
- 建立一个斯科波拉胺诱导的AD老鼠模型.
- 使用新型物体识别和莫里斯水迷宫任务进行行为评估,以评估认知功能.
- 组织学分析 (尼斯尔染色) 和生化分析 (ELISA) 以评估神经元损伤和生物标志物水平 (粉样β,酸化).
- 鼠类皮质的代谢学分析,以确定改变的代谢途径.
- 相关性分析将代谢变化与治疗效果,氧化应激和免疫反应联系起来.
主要成果:
- 在AD大鼠模型中,Anshen Bunao Syrup显著减轻了认知缺陷.
- 治疗抑制了粉样β和酸化的聚合,导致神经元损伤减少.
- 代谢学揭示了酸和脂肪酸代谢途径的显著变化.
- 根据ELISA和相关性分析,Anshen Bunao Syrup可以减轻氧化应激,并通过代谢重塑来调节免疫反应.
结论:
- 在阿尔茨海默病 (AD) 鼠标模型中,Anshen Bunao Syrup显示出显著的神经保护作用.
- 治疗效益与粉样β和tau病理的抑制以及代谢途径的调节有关.
- 安申布纳奥糖作为预防和治疗阿尔茨海默病的潜在治疗剂具有前景.
更多相关视频
07:07Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze
Published on: October 29, 2019
19.1K
08:01Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
42.3K
相关概念视频
Alzheimer's Disease: Treatment
180
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
180
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
120
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
120
Alzheimer's Disease: Overview
465
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
465
